Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorTransplantation ConditioningLeukapheresisTransplantation, HomologousMelphalanBlood Component RemovalAntigens, CD34Hematologic NeoplasmsCombined Modality TherapyCyclophosphamideStem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseHematopoietic Stem CellsBusulfanMyeloablative AgonistsBone Marrow TransplantationGraft SurvivalTreatment OutcomeLymphoma, Non-HodgkinStem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceLeukemiaIfosfamideCarmustineCord Blood Stem Cell TransplantationCytophagocytosisHematopoiesisSalvage TherapyVincristineCytarabineAmyloidosisDisease-Free SurvivalTissue DonorsHodgkin DiseaseTransplantation ChimeraLeukemia, Myeloid, AcuteRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationBlood Cell CountInfectionPlatelet CountHistocompatibilityTime FactorsBlood CellsSurvival AnalysisRecombinant ProteinsDoxorubicinPOEMS SyndromeHistocompatibility TestingPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, T-CellVidarabineImmunosuppressive AgentsCarboplatinTransplantation, IsogeneicBone Marrow PurgingPrednisoneLymphomaDexamethasoneFollow-Up StudiesAntineoplastic AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFeasibility StudiesCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectImmunophenotypingMethotrexateFatal OutcomeBlood DonorsLeukocytes, MononuclearAnemia, AplasticBone MarrowMyelodysplastic SyndromesLymphocyte DepletionHematologic DiseasesLeukocyte CountT-LymphocytesCell SeparationFlow CytometryHistiocytosis, Non-Langerhans-CellEmbryonic Stem CellsBone Marrow DiseasesBreast NeoplasmsImmunomagnetic SeparationNeutropeniaOpportunistic InfectionsCyclosporine